Cargando…
High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
BACKGROUND: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. Characteristic for bone tissue is a high concentration of calcium ions. In this study, we show a promoting effect of an enhanced extracellular calcium concentration on...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945739/ https://www.ncbi.nlm.nih.gov/pubmed/24576174 http://dx.doi.org/10.1186/1476-4598-13-42 |
_version_ | 1782306566005850112 |
---|---|
author | Joeckel, Elke Haber, Tobias Prawitt, Dirk Junker, Kerstin Hampel, Christian Thüroff, Joachim W Roos, Frederik C Brenner, Walburgis |
author_facet | Joeckel, Elke Haber, Tobias Prawitt, Dirk Junker, Kerstin Hampel, Christian Thüroff, Joachim W Roos, Frederik C Brenner, Walburgis |
author_sort | Joeckel, Elke |
collection | PubMed |
description | BACKGROUND: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. Characteristic for bone tissue is a high concentration of calcium ions. In this study, we show a promoting effect of an enhanced extracellular calcium concentration on mechanisms of bone metastasis via the calcium-sensing receptor (CaSR) and its downstream signaling molecules. METHODS: Our analyses were performed using 33 (11/category) matched specimens of normal and tumor tissue and 9 (3/category) primary cells derived from RCC patients of the 3 categories: non-metastasized, metastasized into the lung and metastasized into bones during a five-year period after nephrectomy. Expression of CaSR was determined by RT-PCR, Western blot analyses and flow cytometry, respectively. Cells were treated by calcium and the CaSR inhibitor NPS 2143. Cell migration was measured in a Boyden chamber with calcium (10 μM) as chemotaxin and proliferation by BrdU incorporation. The activity of intracellular signaling mediators was quantified by a phospho-kinase array and Western blot. RESULTS: The expression of CaSR was highest in specimens and cells of patients with bone metastases. Calcium treatment induced an increased migration (19-fold) and proliferation (2.3-fold) exclusively in RCC cells from patients with bone metastases. The CaSR inhibitor NPS 2143 elucidated the role of CaSR on the calcium-dependent effects. After treatment with calcium, the activity of AKT, PLCγ-1, p38α and JNK was clearly enhanced and PTEN expression was almost completely abolished in bone metastasizing RCC cells. CONCLUSIONS: Our results indicate a promoting effect of extracellular calcium on cell migration and proliferation of bone metastasizing RCC cells via highly expressed CaSR and its downstream signaling pathways. Consequently, CaSR may be regarded as a new prognostic marker predicting RCC bone metastasis. |
format | Online Article Text |
id | pubmed-3945739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39457392014-03-08 High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor Joeckel, Elke Haber, Tobias Prawitt, Dirk Junker, Kerstin Hampel, Christian Thüroff, Joachim W Roos, Frederik C Brenner, Walburgis Mol Cancer Research BACKGROUND: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. Characteristic for bone tissue is a high concentration of calcium ions. In this study, we show a promoting effect of an enhanced extracellular calcium concentration on mechanisms of bone metastasis via the calcium-sensing receptor (CaSR) and its downstream signaling molecules. METHODS: Our analyses were performed using 33 (11/category) matched specimens of normal and tumor tissue and 9 (3/category) primary cells derived from RCC patients of the 3 categories: non-metastasized, metastasized into the lung and metastasized into bones during a five-year period after nephrectomy. Expression of CaSR was determined by RT-PCR, Western blot analyses and flow cytometry, respectively. Cells were treated by calcium and the CaSR inhibitor NPS 2143. Cell migration was measured in a Boyden chamber with calcium (10 μM) as chemotaxin and proliferation by BrdU incorporation. The activity of intracellular signaling mediators was quantified by a phospho-kinase array and Western blot. RESULTS: The expression of CaSR was highest in specimens and cells of patients with bone metastases. Calcium treatment induced an increased migration (19-fold) and proliferation (2.3-fold) exclusively in RCC cells from patients with bone metastases. The CaSR inhibitor NPS 2143 elucidated the role of CaSR on the calcium-dependent effects. After treatment with calcium, the activity of AKT, PLCγ-1, p38α and JNK was clearly enhanced and PTEN expression was almost completely abolished in bone metastasizing RCC cells. CONCLUSIONS: Our results indicate a promoting effect of extracellular calcium on cell migration and proliferation of bone metastasizing RCC cells via highly expressed CaSR and its downstream signaling pathways. Consequently, CaSR may be regarded as a new prognostic marker predicting RCC bone metastasis. BioMed Central 2014-02-28 /pmc/articles/PMC3945739/ /pubmed/24576174 http://dx.doi.org/10.1186/1476-4598-13-42 Text en Copyright © 2014 Joeckel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Joeckel, Elke Haber, Tobias Prawitt, Dirk Junker, Kerstin Hampel, Christian Thüroff, Joachim W Roos, Frederik C Brenner, Walburgis High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
title | High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
title_full | High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
title_fullStr | High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
title_full_unstemmed | High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
title_short | High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
title_sort | high calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945739/ https://www.ncbi.nlm.nih.gov/pubmed/24576174 http://dx.doi.org/10.1186/1476-4598-13-42 |
work_keys_str_mv | AT joeckelelke highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT habertobias highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT prawittdirk highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT junkerkerstin highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT hampelchristian highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT thuroffjoachimw highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT roosfrederikc highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor AT brennerwalburgis highcalciumconcentrationinbonespromotesbonemetastasisinrenalcellcarcinomasexpressingcalciumsensingreceptor |